Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer. J Clin Oncol. 2022 05 20; 40(15):1616-1622.
View in:
PubMed
subject areas
Androgen Antagonists
Benzamides
Disease-Free Survival
Hormones
Humans
Male
Nitriles
Phenylthiohydantoin
Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant
Treatment Outcome
authors with profiles
Russell Z. Szmulewitz